Quarterly report pursuant to Section 13 or 15(d)

Segments - Operations and Assets Information (Details)

v3.20.2
Segments - Operations and Assets Information (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Segment Reporting Information [Line Items]          
Total revenues $ 428,064 $ 228,772 $ 940,739 $ 677,592  
Operating Income (loss) 21,939 (39,011) 8,358 (161,588)  
Depreciation and amortization 21,036 23,805 65,295 71,281  
Net income (loss) from investment in investees (110) (294) (433) (2,419)  
Assets 2,371,291   2,371,291   $ 2,309,272
Goodwill 675,795   675,795   671,940
United States          
Segment Reporting Information [Line Items]          
Total revenues 400,778 189,485 847,539 558,688  
Ireland          
Segment Reporting Information [Line Items]          
Total revenues 8,988 22,968 37,736 65,675  
Chile          
Segment Reporting Information [Line Items]          
Total revenues 11,062 8,436 33,064 25,352  
Spain          
Segment Reporting Information [Line Items]          
Total revenues 3,713 4,172 12,005 13,466  
Israel          
Segment Reporting Information [Line Items]          
Total revenues 1,119 1,938 4,010 8,822  
Mexico          
Segment Reporting Information [Line Items]          
Total revenues 2,280 1,642 5,987 5,231  
Other          
Segment Reporting Information [Line Items]          
Total revenues 124 131 398 358  
Corporate          
Segment Reporting Information [Line Items]          
Operating Income (loss) (9,808) (8,416) (26,071) (31,378)  
Depreciation and amortization 0 16 0 54  
Net income (loss) from investment in investees 0 0 0 0  
Assets 44,198   44,198   99,521
Goodwill 0   0   0
Pharmaceutical | Operating Segments          
Segment Reporting Information [Line Items]          
Operating Income (loss) (14,425) (14,232) (34,546) (52,265)  
Depreciation and amortization 7,316 7,673 21,556 22,580  
Net income (loss) from investment in investees (110) (294) (433) (2,419)  
Assets 1,151,065   1,151,065   1,174,639
Goodwill 240,986   240,986   237,131
Diagnostics | Operating Segments          
Segment Reporting Information [Line Items]          
Operating Income (loss) 46,172 (16,363) 68,975 (77,945)  
Depreciation and amortization 13,720 16,116 43,739 48,647  
Net income (loss) from investment in investees 0 0 0 0  
Assets 1,176,028   1,176,028   1,035,112
Goodwill 434,809   434,809   $ 434,809
Services          
Segment Reporting Information [Line Items]          
Total revenues 382,498 181,139 804,309 538,488  
Services | Corporate          
Segment Reporting Information [Line Items]          
Total revenues 0 0 0 0  
Services | Pharmaceutical | Operating Segments          
Segment Reporting Information [Line Items]          
Total revenues 0 0 0 0  
Services | Diagnostics | Operating Segments          
Segment Reporting Information [Line Items]          
Total revenues 382,498 181,139 804,309 538,488  
Products          
Segment Reporting Information [Line Items]          
Total revenues 28,702 26,161 89,133 80,143  
Products | Corporate          
Segment Reporting Information [Line Items]          
Total revenues 0 0 0 0  
Products | Pharmaceutical | Operating Segments          
Segment Reporting Information [Line Items]          
Total revenues 28,702 26,161 89,133 80,143  
Products | Diagnostics | Operating Segments          
Segment Reporting Information [Line Items]          
Total revenues 0 0 0 0  
Transfer of intellectual property and other          
Segment Reporting Information [Line Items]          
Total revenues 16,864 21,472 47,297 58,961  
Transfer of intellectual property and other | Corporate          
Segment Reporting Information [Line Items]          
Total revenues 0 796 0 796  
Transfer of intellectual property and other | Pharmaceutical | Operating Segments          
Segment Reporting Information [Line Items]          
Total revenues 6,819 20,676 31,057 58,165  
Transfer of intellectual property and other | Diagnostics | Operating Segments          
Segment Reporting Information [Line Items]          
Total revenues $ 10,045 $ 0 $ 16,240 $ 0